Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
ZNF282 (Zinc finger protein 282), a novel E2F1 co-activator, promotes esophageal squamous cell carcinoma.
[esophageal squamous cell carcinoma]
Zinc
finger
protein
282
(
ZNF
282
)
is
a
newly
identified
transcription
factor
and
little
is
known
about
its
expression
and
function
.
Originally
,
ZNF
282
is
known
to
bind
U
5
RE
(
U
5
repressive
element
)
of
HLTV-
1
(
human
T
cell
leukemia
virus
type
1
)
with
a
repressive
effect
.
Recently
we
reported
that
ZNF
282
functions
as
an
estrogen
receptor
co
-activator
and
plays
an
essential
role
in
breast
tumorigenesis
.
Although
these
results
suggest
the
possible
role
of
ZNF
282
in
cancers
,
clinical
significance
and
function
of
ZNF
282
are
completely
unknown
in
most
of
cancers
.
Here
we
found
that
ZNF
282
was
frequently
overexpressed
in
esophageal
squamous
cell
carcinoma
(
ESCC
)
(
n
=
165
)
compared
with
normal
esophageal
epithelium
and
its
overexpression
was
correlated
with
adverse
clinical
outcome
.
Multivariate
survival
analysis
indicated
that
ZNF
282
expression
was
an
independent
prognostic
predictor
for
poor
survival
in
ESCC
(
HR
:
2
.
56
(
95
%
CI
1
.
54
-
4
.
26
)
,
p
<
0
.
001
)
.
In
addition
,
depletion
of
ZNF
282
inhibited
the
cell
cycle
progression
,
migration
,
and
invasion
of
ESCC
cells
and
reduced
the
tumorigenicity
of
ESCC
xenograft
in
nude
mouse
.
We
further
showed
that
ZNF
282
is
required
for
E
2
F
1
-
mediated
gene
expression
in
ESCC
cells
.
Thus
,
ZNF
282
is
E
2
F
1
co
-activator
involved
in
ESCC
and
elevated
expression
of
ZNF
282
is
an
independent
adverse
prognostic
factor
in
ESCC
.
Diseases
Validation
Diseases presenting
"elevated expression"
symptom
epidermolysis bullosa simplex
esophageal squamous cell carcinoma
krabbe disease
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom